Received Jun 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
3 weeks later he started a rash; This is a spontaneous report received from a Consumer or other non HCP. A male patient received BNT162b2 (BNT162B2), on 22Oct2021 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for Covid-19 Immunization. The following information was reported: RASH (non-serious) with onset Nov2021, 3 weeks after the suspect product(s) administration, outcome "not recovered", described as "3 weeks later he started a rash". The event "3 weeks later he started a rash" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of rash. Additional information: The reporter's husband received his 1st covid booster 22Oct2021. 3 weeks later he started a rash. 4 doctors, numerous ointments, light box treatments and then medication orally, the rash was not only still there, but was spreading. Doctors had taken various tests and punch biopsies, and no one knew what the rash was. Ruled out various common skin disorders, all negative. Reporter stated that need your help to see if this was a bad reaction to a chemical in the booster shot he received. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received
Test Name: Punch biopsies; Result Unstructured Data: Test Result:Result unknown; Test Name: Various tests; Result Unstructured Data: Test Result:Result unknown